Koninklijke Philips NVRYLPF 73 PS Ratio is 1.23 as of Jun. 25, 2026, which is 20% below its 10-year median of 1.54. GuruFocus rates RYLPF with a GF Score™ of 73/100 and a GF Value™ of $25.13 (Fairly Valued). The stock has 2 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Koninklijke Philips NV ranks better than 74.75% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Koninklijke Philips NV's share price is $26.192.
Koninklijke Philips NV's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $21.29. Hence, Koninklijke Philips NV's PS Ratio for today is 1.23.
The historical rank and industry rank for Koninklijke Philips NV's PS Ratio or its related term are showing as below:
RYLPF'
s PS Ratio Range Over the Past 10 Years
Min: 0.64 Med: 1.54 Max: 2.83
Current: 1.28
During the past 13 years, Koninklijke Philips NV's highest PS Ratio was 2.83. The lowest was 0.64. And the median was 1.54.
RYLPF's PS Ratio is ranked better than 74.75% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.855
vs RYLPF: 1.28
Koninklijke Philips NV revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Koninklijke Philips NV was -5.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -0.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 1.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 1.50% per year.
During the past 13 years, Koninklijke Philips NV's highest 3-Year average Revenue per Share Growth Rate was 64.60% per year. The lowest was -33.60% per year. And the median was -0.20% per year.
Back to Basics: PS Ratio
Koninklijke Philips NV (OTCPK:RYLPF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Koninklijke Philips NV's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koninklijke Philips NV PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's PS Ratio distribution charts can be found below:
* The bar in red indicates where Koninklijke Philips NV's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Koninklijke Philips NV's Share Price of today is $26.192. Koninklijke Philips NV's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $21.29.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Koninklijke Philips NV (RYLPF) has a PS Ratio of 1.23 as of Jun. 25, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Koninklijke Philips NV and its competitors. This is 20% below median its historical median of 1.54. Over the past decade, Koninklijke Philips NV's PS Ratio has ranged from 0.64 to 2.83. According to the industry distribution chart, Koninklijke Philips NV ranks #203 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 25.2%.
Is Koninklijke Philips NV's PS Ratio too high?
Koninklijke Philips NV's current PS Ratio of 1.23 is 20% below median its 10-year median of 1.54. Over the past 10 years, this metric has ranged from a low of 0.64 to a high of 2.83. The Medical Devices & Instruments industry median PS Ratio is 2.86. Koninklijke Philips NV's value of 1.23 is 56.9% below this industry median. Based on the distribution chart, Koninklijke Philips NV ranks #203 out of 804 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Koninklijke Philips NV has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #203 out of 804 companies for PS Ratio. This puts Koninklijke Philips NV in the upper half of its industry. The industry median PS Ratio is 2.86. Koninklijke Philips NV's value of 1.23 is 56.9% below this benchmark. Historically, Koninklijke Philips NV's own PS Ratio has ranged from 0.64 to 2.83 over the past decade. While the company's 10-year median is 1.54 vs. the industry median of 2.86, Koninklijke Philips NV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.86, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koninklijke Philips NV's current PS Ratio of 1.23 is 56.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Koninklijke Philips NV and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koninklijke Philips NV's current PS Ratio is 1.23, which is 20% below median its own 10-year median of 1.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $25.13, compared to a current price of $26.19 — trading 4.2% above its estimated fair value. The current PS Ratio is 1.23, which is 20% below median its 10-year median of 1.54 and 56.9% below the Medical Devices & Instruments industry median of 2.86. Koninklijke Philips NV's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current PS Ratio is 1.23 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued.
The current stock price of $26.19 is trading 4.2% above its estimated GF Value™ of $25.13.
GuruFocus considers Koninklijke Philips NV to be Fairly Valued.
Key valuation signals for RYLPF:
PS Ratio: 1.23 (20% below median its 10-year median of 1.54)
GF Value™: $25.13 vs. price of $26.19 (4.2% above fair value)
Industry Position: 56.9% below the Medical Devices & Instruments median (#203 of 804)
No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
73GF Score
Get the complete analysis for RYLPF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYLPF has been successfully added to your 
